Quarterly Report • Jan 2, 2024
Quarterly Report
Open in ViewerOpens in native device viewer
For the month of December 2023 Commission File Number: 001-35284
Ellomay Capital Ltd. (Translation of registrant's name into English)
18 Rothschild Blvd., Tel Aviv 6688121, Israel (Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
$$\begin{array}{ccc} \text{Yes} & \begin{bmatrix} \end{bmatrix} & \begin{array}{c} \end{array} & \begin{array}{c} \text{No} \end{array} \begin{array}{c} \text{[X]} \end{array} \end{array}$$
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________
THE IFRS FINANCIAL RESULTS INCLUDED IN EXHIBIT 99.1 OF THIS FORM 6-K ARE HEREBY INCORPORATED BY REFERENCE INTO THE REGISTRANT'S REGISTRATION STATEMENTS ON FORM F-3 (NOS. 333-199696 AND 333-144171) AND FORM S-8 (NOS. 333- 187533, 333-102288 AND 333-92491), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
This Report on Form 6-K of Ellomay Capital Ltd. consists of the following document, which is attached hereto and incorporated by reference herein:
Exhibit 99.1 Press Release: "Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2023," dated December 31, 2023.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Ellomay Capital Ltd.
By: /s/ Ran Fridrich Ran Fridrich Chief Executive Officer and Director
Dated: January 2, 2024

Tel-Aviv, Israel, December 31, 2023 – Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today reported unaudited financial results for the three and nine month periods ended September 30, 2023.
• On October 7, 2023, the "Iron Swards" war broke out in Israel following an attack in Southern Israel by Hamas. The war and hostilities, including missile attacks, mainly on southern and northern Israel, have continued since then. The substantial majority of the Company's operating facilities, which serve as the Company's main sources of liquidity, are located outside of Israel, in Spain and the Netherlands. The substantial majority of the projects under development of the Company are also located outside of Israel, in Italy, the US and Spain. These facilities and projects were not impacted by the war and hostilities in Israel. The Company's headquarters are located in Tel Aviv, which is in central Israel, and the Company's headquarter work continued uninterrupted throughout the war and hostilities.
The Company has three assets that are currently operating or under construction in Israel: (i) the Talmei Yosef PV Facility (100% owned by the Company, in southern Israel), (ii) the Pumped Storage Project in the Manara Cliff (83.34% owned by the Company, in northern Israel), and (iii) the Dorad power plant (9.375% owned by the Company, in southern Israel). As previously published by the Company, the construction works on the Manara site stopped in early October 2023 and the contractor is using this period in which construction is halted to continue the planning work and advancing the project. The Company expects to receive compensation for the delays through the fees that will be paid for the electricity and availability after the project becomes operational and through direct compensation for damages. The Talmei Yosef facility and the Dorad power plant have not been materially impacted by the war and are currently fully operational. The continuation or future escalation of the war and hostilities in southern and northern Israel, including potential direct damage due to missile attacks, temporary or permanents cessation of operations and potential inability to access the sites, could materially adversely impact the Company's Israeli operations and projects under development and the Company's results of operations.
The first nine months of 2023 were characterized by a decline in the electricity prices in Europe compared to 2022. The decrease is mainly evident in Spain, whereas in Italy the prices remained stable. Despite the decrease in electricity prices in Spain, the EBITDA for the period increased by approximately €2.3 million compared to the same period last year, and amounted to approximately €21.5 million. The Dorad power station showed an increase in revenues and net income and this trend is expected to continue also during next year. The development activities of solar projects in the USA is continuing and their construction is expected to commence in the beginning of 2024. In Italy, the construction of a solar project with a capacity of 18 MW commenced, in addition to solar projects with a capacity of 20 MW whose construction finished and they are awaiting connection to the grid.
The Company's operations concentrate on three main fields:
The Company's revenues for the quarter were approximately €15.6 million, a small decrease compared to the same period last year, despite the decrease in electricity prices compared to the same period last year. The operating profit increased by approximately €3 million, mainly as a result of the increase in Dorad's profit.
The net profit for the third quarter of 2023 was approximately €5.9 million and the net profit for the first nine months of 2023 was approximately €10.5 million.
The Talasol solar project (300 solar MW) (Company's share is 51%) produced during the third quarter revenues from the sale of electricity and green certificates of approximately €8.9 million. Talasol is a party to a financial hedge of its electricity capture price (PPA). Approximately 80% of its production (75% based on P-50) are sold under this agreement for a fixed price. The remaining electricity produced by Talasol is sold directly to the grid, at spot prices.
The Ellomay Solar project (28 solar MW) produced during the third quarter of 2023 revenues from the sale of electricity and green certificates of approximately €1.5 million.
The Company has approximately 505 solar MW projects under advanced development stages, of which licenses have been obtained for approximately 203 MW. Projects with an aggregate capacity of 20 MW are expected to be connected to the grid during the coming month. Preliminary construction works in projects with an aggregate capacity of approximately 105 MW commenced during the third quarter of 2023 and construction works in the remainder of the licenses (approximately 78 MW) are expected to commence in early 2024.
The Company has additional projects in early development stages (in addition to the 505 MW in advanced development stages), the intention of the Company is to reach a portfolio of approximately 1,000 solar MW by the end of 2026.
The Manara Pumped Storage Project (Company's share is 83.34%): The Manara Cliff pumped storage project, with a capacity of 156 MW, is in advanced construction stages. The Iron Swards War, which commenced on October 7, 2023, stopped the construction works on the project. The project has full protection for damages and losses due to the war within the framework of covenants that support financing provided by the Israeli state as part of the tariff regulation. The project is expected to reach commercial operation during the first half of 2027, and to produce average annual revenues of approximately €74 million and EBITDA of approximately €33 million. 1 The Company and its partner in the project, Ampa, invested the equity required for the project (other than linkage differences), and the remainder of the funding is from a consortium of lenders led by Mizrahi Bank, at a scope of approximately NIS 1.18 billion.
Projects no. 1 and 2 are based on tender No. 1 that the Company won and there is an option of transition to regulation that enables a direct sale to end customers.
Dorad Power Station (Company's share is approximately 9.4%): the gas flow from the Karish reservoir that began in November 2022 reduced the gas costs of Dorad. Dorad benefited from the increase in the TAOZ and the production component compared to the same period last year. In addition, the Israeli Electricity Authority's resolution in connection with the changes of the hourly tariffs, which entered into force in January 2023, means an extension of the "summer" period (a month was added to the "summer" season in which the tariffs are higher), the elimination of the "GEVA" (average consumption) hours and the change in the "PISGA" (peak) hours in the intermediate seasons to the afternoon and evening. As a result, Dorad provides availability to the system manager for the "SHEFEL" (low) period, which is longer and the demand of the system manager is higher. As a result of the continuous operations of the power plant, the maintenance expenses decreased and the hours of operation increased, increasing production and the revenues and profit. Moreover, the Israeli government decided to increase the power
1 EBITDA is a non-IFRS measure. The Company is unable to provide a reconciliation of the Manara Project's EBITDA to the Manara Project's net profit/loss on a forward-looking basis without unreasonable effort because items that impact this IFRS financial measure are not within the Company's control and/or cannot be reasonably predicted. These items include, among others, exchange rate fluctuations, depreciation and amortization, other income, finance income, finance expenses and taxes on income. Such items may have a significant impact on the future financial results and the Company believes such a reconciliation for the projected results will not be meaningful.
station by an additional 650 MW and the National Infrastructure Committee approved the TTL/11/B plan – expansion of the Dorad power station.
In June 2023, an arbitration award was given that, among other issues, obligated Zorlu and Edeltech to refund approximately \$130 million to Dorad and to pay the derivative plaintiffs NIS 20 million as reimbursement of legal expenses. Appeals on the arbitration award were submitted by both parties and the appeal process was agreed in advance and is expected to end in the first quarter of 2024.
In connection with the military conflict in Ukraine and the stoppage of Russian gas supply to Europe, there are substantial changes in the field of biogas in the Netherlands and Europe. Europe in general and the Netherlands specifically have set ambitious goals for increasing gas production from waste. Various incentives are being considered, the main one is increasing the price of the green certificates. The price of these certificates has increased from approximately 13–15 euro cents per cubic meter to around 45 euro cents per cubic meter. The prices of greed certificates continue to rise and the expectation is that the price will reach approximately 60 euro cents per cubic meter in 2024.
The Company estimates that with the increasing importance of the biogas field, this field entered into a new era. In the Netherlands, new legislation was adopted that obliges the gas suppliers to incorporate green gas in a scope of up to 20% of the amount supplied by them, valid commencing January 1, 2025. This legislation and the growing demand for green certificates derived from the biogas industry, is expected to add and significantly improve the results of the biogas segment of the Company.
The Company executed a joint development agreement for the development of solar projects in the State of Texas, USA. The agreement covers an initial two projects, with an aggregate installed capacity of 26 MW DC, and an option for two additional projects under similar terms with an aggregate installed capacity of 20 MW DC. The first two projects have reached ready-to-build status, commencement of construction is expected in the beginning of 2024 and they are expected to be constructed within 8-10 months. One of the two additional projects has also reached ready-to-build status and the other additional project is expected to achieve ready-to-build status during the first quarter of 2024. It is expected that the two additional projects will be constructed during the second half of 2024. The estimated capital cost for the first two projects is \$30-\$32 million, of which the Company's share is expected to be approximately \$19-\$21 million. The estimated capital cost for the two additional projects is \$24-\$26 million, of which the Company's share is expected to be \$15-\$17 million. The remaining capital costs are expected to be covered by tax equity partners.
EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 14 of this press release.
Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe, USA and Israel.
To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, The Netherlands and Texas, USA, including:
For more information about Ellomay, visit http://www.ellomay.com.
This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including changes in electricity prices and demand, the impact of the war and hostilities in Israel and Gaza, regulatory changes, including extension of current or approval of new rules and regulations increasing the operating expenses of manufacturers of renewable energy in Spain, increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, the impact of the continued military conflict between Russia and Ukraine, technical and other disruptions in the operations or construction of the power plants owned by the Company and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: Kalia Rubenbach (Weintraub) CFO Tel: +972 (3) 797-1111 Email: [email protected]
| Unaudited Condensed Consolidated Interim Statements of Financial Position | ||
|---|---|---|
| September 30, | December 31, | September 30, | |||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | |||
| € in thousands | Convenience Translation into US\$ in thousands* |
||||
| Assets | |||||
| Current assets: | |||||
| Cash and cash equivalents | 62,099 | 46,458 | 65,819 | ||
| Marketable securities | - | 2,836 | - | ||
| Short term deposits Restricted cash |
999 810 |
- 900 |
1,059 859 |
||
| Receivable from concession project | 1,739 | 1,799 | 1,843 | ||
| Intangible asset from green certificates | 1,457 | 585 | 1,544 | ||
| Trade and other receivables | 12,230 | 12,097 | 12,963 | ||
| 79,334 | 64,675 | 84,087 | |||
| Non-current assets | |||||
| Investment in equity accounted investee | 32,098 | 30,029 | 34,021 | ||
| Advances on account of investments | 1,195 | 2,328 | 1,267 | ||
| Receivable from concession project | 21,702 | 24,795 | 23,002 | ||
| Fixed assets | 400,751 | 365,756 | 424,760 | ||
| Right-of-use asset | 32,521 | 30,020 | 34,469 | ||
| Intangible asset | 3,532 | 4,094 | 3,744 | ||
| Restricted cash and deposits | 18,974 | 20,192 | 20,111 | ||
| Deferred tax Long term receivables |
11,230 9,763 |
23,510 9,270 |
11,903 10,348 |
||
| Derivatives | 1,199 | 1,488 | 1,271 | ||
| 532,965 | 511,482 | 564,896 | |||
| Total assets | 612,299 | 576,157 | 648,983 | ||
| Liabilities and Equity | |||||
| Current liabilities | |||||
| Current maturities of long-term bank loans | 11,860 | 12,815 | 12,571 | ||
| Current maturities of other long-term loans | 5,000 | 10,000 | 5,300 | ||
| Current maturities of debentures | 35,331 | 18,714 | 37,448 | ||
| Trade payables | 5,263 | 4,504 | 5,577 | ||
| Other payables | 15,650 | 11,207 | 16,588 | ||
| Current maturities of derivatives | 2,327 | 33,183 | 2,466 | ||
| Current maturities of lease liabilities | 789 | 745 | 836 | ||
| 76,220 | 91,168 | 80,786 | |||
| Non-current liabilities | |||||
| Long-term lease liabilities | 25,100 | 22,005 | 26,604 | ||
| Long-term bank loans | 242,594 | 229,466 | 257,128 | ||
| Other long-term loans | 28,558 | 21,582 | 30,269 | ||
| Debentures | 103,190 | 91,714 | 109,372 | ||
| Deferred tax Other long-term liabilities |
6,032 1,014 |
6,770 2,021 |
6,393 1,075 |
||
| Derivatives | 4,404 | 28,354 | 4,668 | ||
| 410,892 | 401,912 | 435,509 | |||
| Total liabilities | 487,112 | 493,080 | 516,295 | ||
| Equity Share capital |
|||||
| 25,613 | 25,613 | 27,148 | |||
| Share premium | 86,131 | 86,038 | 91,291 | ||
| Treasury shares | (1,736) | (1,736) | (1,840) | ||
| Transaction reserve with non-controlling Interests | 5,697 | 5,697 | 6,038 | ||
| Reserves | (873) | (12,632) | (925) | ||
| Retained earnings (accumulated deficit) | 3,453 | (7,256) | 3,660 | ||
| Total equity attributed to shareholders of the Company | 118,285 | 95,724 | 125,372 | ||
| Non-Controlling Interest | 6,902 | (12,647) | 7,316 | ||
| Total equity | 125,187 | 83,077 | 132,688 | ||
| Total liabilities and equity | 612,299 | 576,157 | 648,983 |
* Convenience translation into US\$ (exchange rate as at September 30, 2023: euro 1 = US\$ 1.06)
| 2023 | For the Three months ended September 30, 2022 |
2023 | For the nine months ended September 30, 2022 |
For the year ended December 31, 2022 |
For the nine months ended September 30, 2023 |
||
|---|---|---|---|---|---|---|---|
| € in thousands | € in thousands | € in thousands |
Convenience Translation into US\$ in thousands** |
||||
| Revenues | 15,644 | 15,529 | 41,102 | 44,725 | 53,360 | 43,564 | |
| Operating expenses | (5,653) | (5,297) | (17,681) | (18,429) | (24,089) | (18,740) | |
| Depreciation and amortization expenses | (4,031) | (3,873) | (12,095) | (11,851) | (16,092) | (12,820) | |
| Gross profit | 5,960 | 6,359 | 11,326 | 14,445 | 13,179 | 12,004 | |
| Project development costs | (248) | (1,126) | (2,440) | (2,680) | (3,784) | (2,586) | |
| General and administrative expenses | (1,193) | (1,669) | (4,104) | (4,966) | (5,892) | (4,350) | |
| Share of profits (losses) of equity accounted investee | 3,058 | 1,158 | 4,599 | 556 | 1,206 | 4,875 | |
| Operating profit | 7,577 | 4,722 | 9,381 | 7,355 | 4,709 | 9,943 | |
| Financing income Financing income (expenses) in connection with derivatives |
2,059 | 844 | 11,080 | 2,655 | 9,565 | 11,744 | |
| and warrants, net | 391 | 677 | (85) | 1,015 | 605 | (90) | |
| Financing expenses in connection with projects finance | (1,830) | (1,957) | (5,612) | (5,846) | (7,765) | (5,948) | |
| Financing expenses in connection with debentures | (1,028) | (943) | (2,868) | (2,286) | (2,130) | (3,040) | |
| Interest expenses on minority shareholder loan | (540) (10) |
(331) (3,850) |
(1,473) (444) |
(1,223) (2,056) |
(1,529) (1,212) |
(1,561) (471) |
|
| Other financing expenses Financing income (expenses), net |
(958) | (5,560) | 598 | (7,741) | (2,466) | 634 | |
| Profit (loss) before taxes on income | 6,619 | (838) | 9,979 | (386) | 2,243 | 10,577 | |
| Tax benefit (Taxes on income) | (742) | (863) | 461 | (1,950) | (2,103) | 489 | |
| Profit (loss) for the period | 5,877 | (1,701) | 10,440 | (2,336) | 140 | 11,066 | |
| Profit (loss) attributable to: | |||||||
| Owners of the Company | |||||||
| Non-controlling interests | 5,233 644 |
(2,564) 863 |
10,709 (269) |
(3,786) 1,450 |
(357) 497 |
11,351 (285) |
|
| Profit (loss) for the period | 5,877 | (1,701) | 10,440 | (2,336) | 140 | 11,066 | |
| Other comprehensive income (loss) item that after initial recognition in comprehensive income (loss) were or will be transferred to profit or loss: |
|||||||
| Foreign currency translation differences for foreign operations | (930) | *4,889 | (9,183) | *1,206 | *(7,829) | (9,733) | |
| Effective portion of change in fair value of cash flow hedges Net change in fair value of cash flow hedges transferred to |
5,949 | *(20,805) | 50,149 | *(29,680) | *8,976 | 53,154 | |
| profit or loss | (4,580) | *(11,074) | (9,389) | *(33,320) | *(36,438) | (9,952) | |
| Total other comprehensive income (loss) | 439 | (26,990) | 31,577 | (61,794) | (35,291) | 33,469 | |
| Total other comprehensive income (loss) attributable to: | |||||||
| Owners of the Company | (296) | (10,451) | 11,759 | (29,502) | (19,920) | 12,464 | |
| Non-controlling interests | 735 | (16,539) | 19,818 | (32,292) | (15,371) | 21,005 | |
| Total other comprehensive income (loss) for the period | 439 | (26,990) | 31,577 | (61,794) | (35,291) | 33,469 | |
| Total comprehensive income (loss) for the period | 6,316 | (28,691) | 42,017 | (64,130) | (35,151) | 44,535 | |
| Total comprehensive income (loss) attributable to: Owners of the Company |
4,937 | (13,015) | 22,468 | (33,288) | (20,277) | 23,815 | |
| Non-controlling interests | 1,379 | (15,676) | 19,549 | (30,842) | (14,874) | 20,720 | |
| Total comprehensive income (loss) for the period | 6,316 | (28,691) | 42,017 | (64,130) | (35,151) | 44,535 | |
| Basic net earnings (loss) per share | 0.41 | (0.20) | 0.83 | (0.29) | (0.03) | 0.88 | |
| Diluted net earnings (loss) per share | 0.41 | (0.20) | 0.83 | (0.29) | (0.03) | 0.88 | |
* Reclassified
** Convenience translation into US\$ (exchange rate as at September 30, 2023: euro 1 = US\$ 1.06)
| Attributable to shareholders of the Company | Non- controlling Interests |
Total Equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Retained earnings (accumulated Deficit) |
Treasury shares |
Translation reserve from foreign operations |
Hedging Reserve € in thousands |
Interests Transaction reserve with non-controlling Interests |
Total | |||
| For the nine months ended September 30, 2023: Balance as at January 1, 2023 Profit (loss) for the period Other comprehensive loss for the period Total comprehensive loss for the period |
25,613 - - - |
86,038 - - - |
(7,256) 10,709 - 10,709 |
(1,736) - - - |
7,970 - (8,771) (8,771) |
(20,602) - 20,530 20,530 |
5,697 - - - |
95,724 10,709 11,759 22,468 |
(12,647) (269) 19,818 19,549 |
83,077 10,440 31,577 42,017 |
| Transactions with owners of the Company, recognized directly in equity: Share-based payments |
- | 93 | - | - | - | - | - | 93 | - | 93 |
| Balance as at September 30, 2023 |
25,613 | 86,131 | 3,453 | (1,736) | (801) | (72) | 5,697 | 118,285 | 6,902 | 125,187 |
| For the nine months ended September 30, 2022: Balance as at January 1, 2022 Profit (loss) for the period Other comprehensive income (loss) for the period |
25,605 - - |
85,883 - - |
(6,899) (3,786) - |
(1,736) - - |
15,365 - 1,152 |
(8,077) - (30,654) |
5,697 - - |
115,838 (3,786) (29,502) |
(1,731) 1,450 (32,292) |
114,107 (2,336) (61,794) |
| Total comprehensive income (loss) for the period | - | - | (3,786) | - | 1,152 | (30,654) | - | (33,288) | (30,842) | (64,130) |
| Transactions with owners of the Company, recognized directly in equity: Issuance of Capital note to non-controlling interest Share-based payments Balance as at September 30, 2022 |
- - 25,605 |
- 90 85,973 |
- - (10,685) |
- - (1,736) |
- - 16,517 |
- - (38,731) |
- - 5,697 |
- 90 82,640 |
3,958 - (28,615) |
3,958 90 54,025 |
| Attributable to shareholders of the Company | Non controlling Interests |
Total Equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Accumulated deficit |
Treasury shares |
Translation reserve from foreign operations |
Hedging Reserve € in thousands |
Interests Transaction reserve with non-controlling Interests |
Total | |||
| For the year ended December 31, 2022: Balance as at January 1, 2022 Profit (loss) for the year |
25,605 - |
85,883 - |
(6,899) (357) |
(1,736) - |
15,365 - |
(8,077) - |
5,697 - |
115,838 (357) |
(1,731) 497 |
114,107 140 |
| Other comprehensive loss for the year Total comprehensive loss for the year Transactions with owners of the Company, recognized directly in equity: |
- - |
- - |
- (357) |
- - |
(7,395) (7,395) |
(12,525) (12,525) |
- - |
(19,920) (20,277) |
(15,371) (14,874) |
(35,291) (35,151) |
| Issuance of Capital note to non-controlling interest Options exercise Share-based payments |
- 8 - |
- 28 127 |
- - - |
- - - |
- - - |
- - - |
- - - |
- 36 127 |
3,958 - - |
3,958 36 127 |
| Balance as at December 31, 2022 | 25,613 | 86,038 | (7,256) | (1,736) | 7,970 | (20,602) | 5,697 | 95,724 | (12,647) | 83,077 |
| Non controlling |
Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attributable to shareholders of the Company | Interests | Equity | ||||||||||
| Interests | ||||||||||||
| Retained | Translation | Transaction | ||||||||||
| earnings | reserve from | reserve with | ||||||||||
| Share | Share | (accumulated | Treasury | foreign | Hedging | non-controlling | ||||||
| capital | premium | deficit) | shares | operations | Reserve | Interests | Total | |||||
| Convenience translation into US\$ (exchange rate as at September 30, 2023: euro 1 = US\$ 1.06) |
||||||||||||
| For the nine months ended September 30, 2023: |
||||||||||||
| Balance as at January 1, 2023 | 27,148 | 91,192 | (7,691) | (1,840) | 8,447 | (21,836) | 6,038 | 101,458 | (13,404) | 88,054 | ||
| Profit (loss) for the period | - | - | 11,351 | - | - | - | - | 11,351 | (285) | 11,066 | ||
| Other comprehensive loss for the period | - | - | - | - | (9,296) | 21,760 | - | 12,464 | 21,005 | 33,469 | ||
| Total comprehensive loss for the period | - | - | 11,351 | - | (9,296) | 21,760 | - | 23,815 | 20,720 | 44,535 | ||
| Transactions with owners of the Company, | ||||||||||||
| recognized directly in equity: |
||||||||||||
| Share-based payments | - | 99 | - | - | - | - | - | 99 | - | 99 | ||
| Balance as at September 30, 2023 |
27,148 | 91,291 | 3,660 | (1,840) | (849) | (76) | 6,038 | 125,372 | 7,316 | 132,688 | ||
| For the three months ended September 30 , |
For the nine months ended September 30 , |
For the year ended December 31, |
For the nine months ended September 30 |
||||
|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | 2022 | 2023 Convenience Translation into US\$* |
||
| € in thousands | |||||||
| Cash flows from operating activities | |||||||
| Profit (loss) for the period | 5,877 | (1,701) | 10,440 | (2,336) | 140 | 11,066 | |
| Adjustments for: | |||||||
| Financing expenses, net | 958 | 5,560 | (598) | 7,741 | 2,466 | (634) | |
| Depreciation and amortization Share-based payment transactions |
4,031 31 |
3,873 30 |
12,095 93 |
11,851 90 |
16,092 127 |
12,820 99 |
|
| Share of losses (profits) of equity accounted investees | (3,058) | (1,158) | (4,599) | (556) | (1,206) | (4,875) | |
| Payment of interest on loan by an equity accounted investee |
1,468 | - | 1,468 | - | - | 1,556 | |
| Change in trade receivables and other receivables | 457 | 2,862 | 1,015 | 283 | 724 | 1,076 | |
| Change in other assets | (595) | (163) | (750) | (110) | (209) | (795) | |
| Change in receivables from concessions project | 683 | 77 | 1,519 | (473) | )521( | 1,610 | |
| Change in trade payables | 1,696 | 47 | 287 | (754) | 1,697 | 304 | |
| Change in other payables | (126) | (3,480) | 257 | 4,398 | 3,807 | 272 | |
| Income tax expense (tax benefit) | 742 | 863 | (461) | 1,950 | 2,103 | (489) | |
| Income taxes paid | (419) | (1,144) | (439) | (4,399) | (6,337) | (465) | |
| Interest received | 1,059 | 481 | 2,412 | 1,403 | 1,896 | 2,557 | |
| Interest paid | (1,286) | (260) | (5,950) | (5,184) | (9,459) | (6,306) | |
| Net cash provided by (used in) operating activities | 11,518 | 5,887 | 16,789 | 13,904 | 11,320 | 17,796 | |
| Cash flows from investing activities | |||||||
| Acquisition of fixed assets | (24,015) | (16,793) | (51,483) | (39,067) | (48,610) | (54,567) | |
| Repayment of loan by an equity accounted investee | 103 | - | 103 | 149 | 149 | 109 | |
| Loan to an equity accounted investee | - | (60) | (68) | (60) | (128) | (72) | |
| Advances on account of investments | - | - | (421) | - | )774( | (446) | |
| Proceeds from repayment of advances on account of | |||||||
| investments in process | 2,277 | - | 1,921 | - | - | 2,036 | |
| Settlement of derivatives contract | - | 3,800 | - | 3,272 | (528) | - | |
| Proceeds from (investment in) in restricted cash, net | - | (639) | 893 | (8,880) | (4,873) | 947 | |
| Proceeds from (investment in) in short term deposit Proceeds from (investment in) marketable securities |
165 - |
- - |
(1,092) 2,837 |
27,645 - |
27,645 (1,062) |
(1,157) 3,007 |
|
| Net cash provided by (used in) investing activities | (21,470) | (13,692) | (47,310) | (16,941) | (28,181) | (50,143) | |
| Cash flows from financing activities | |||||||
| Proceeds from options | - | - | - | - | 36 | - | |
| Cost associated with long term loans | (481) | (1,033) | (1,187) | (9,991) | (9,988) | (1,258) | |
| Payment of principal of lease liabilities | (189) | (1,575) | (966) | (5,548) | (5,703) | (1,024) | |
| Proceeds from long term loans | - | - | 21,370 | 196,162 | 215,170 | 22,650 | |
| Repayment of long-term loans | (517) | (5,348) | (6,990) | (148,443) | (153,751) | (7,409) | |
| Repayment of Debentures | - | - | (17,763) | (19,764) | (19,764) | (18,827) | |
| Repayment of SWAP instrument associated with long term loans |
- | - | - | (3,290) | )3,290( | - | |
| Proceeds from issuance of Debentures, net | - | - | 55,808 | - | - | 59,152 | |
| Proceeds from settlement of derivatives, net | - | - | - | - | 3,800 | - | |
| Net cash provided by (used in) financing activities | (1,187) | (7,956) | 50,272 | 9,126 | 26,510 | 53,284 | |
| Effect of exchange rate fluctuations on cash and cash | |||||||
| equivalents | (632) | 4,297 | (4,110) | 1,169 | (4,420) | (4,359) | |
| Increase (decrease) in cash and cash equivalents Cash and cash equivalents at the beginning of the period |
(11,771) 73,870 |
(11,464) 59,951 |
15,641 46,458 |
7,258 41,229 |
5,229 41,229 |
16,578 49,241 |
|
| Cash and cash equivalents at the end of the period | 62,099 | 48,487 | 62,099 | 48,487 | 46,458 | 65,819 | |
* Convenience translation into US\$ (exchange rate as at September 30, 2023: euro 1 = US\$ 1.06)
| PV Ellomay |
Bio | Total reportable |
Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Italy | Spain | Solar | Talasol | USA | Israel | Gas | Dorad | Manara | segments | Reconciliations | consolidated | |
| For the nine | months ended September | 30, 2023 | ||||||||||
| € in thousands | ||||||||||||
| Revenues | - | 2,246 | 3,565 | 21,542 | - | 692 | 13,057 | 51,901 | - | 93,003 | (51,901) | 41,102 |
| Operating expenses | - | (395) | (1,397) | (4,297) | - | (280) | (11,312) | (37,544) | - | (55,225) | 37,544 | (17,681) |
| Depreciation expenses | (1) | (686) | (707) | (8,571) | - | (348) | (1,764) | (4,343) | - | (16,420) | 4,325 | (12,095) |
| Gross profit (loss) | (1) | 1,165 | 1,461 | 8,674 | - | 64 | (19) | 10,014 | - | 21,358 | (10,032) | 11,326 |
| Adjusted Gross profit (loss) Project development costs |
(1) | 1,165 | 1,461 | 8,674 | - | 1,2552 | (19) | 10,014 | - | 22,549 | (11,223) | 11,326 (2,440) |
| General and administrative expenses | (4,104) | |||||||||||
| Share of loss of equity accounted investee | 4,599 | |||||||||||
| Operating profit | 9,381 | |||||||||||
| Financing income Financing expenses in connection with derivatives and |
11,080 | |||||||||||
| warrants, net | (85) | |||||||||||
| Financing expenses in connection with projects finance | (5,612) | |||||||||||
| Financing expenses in connection with debentures | (2,868) | |||||||||||
| Interest expenses on minority shareholder loan | (1,473) | |||||||||||
| Other financing expenses | (444) | |||||||||||
| Financing expenses, net | 598 | |||||||||||
| Income before taxes on Income | 9,979 | |||||||||||
| Segment assets as at September 30, 2023 |
39,329 | 13,971 | 18,957 | 234,415 | 5,536 | 31,543 | 32,141 | 103,334 | 155,589 | 634,815 | (22,517) | 612,299 |
2 The gross profit of the Talmei Yosef PV Plant located in Israel is adjusted to include income from the sale of electricity (approximately €3,261 thousand) and depreciation expenses (approximately €1,726 thousand) under the fixed asset model, which were not recognized as revenues and depreciation expenses, respectively, under the financial asset model as per IFRIC 12.
| For the three months ended September 30, |
For the nine September 30, |
months ended | For the year ended December 31, |
For the nine months ended September 30, 2023 |
|||
|---|---|---|---|---|---|---|---|
| 2023 2022 |
2023 | 2022 | 2022 | ||||
| € in thousands | Convenience Translation into US\$ in thousands* |
||||||
| Net profit (loss) for the period | 5,877 | (1,701) | 10,440 | (2,336) | 140 | 11,066 | |
| Financing (income) expenses, net | 958 | 5,560 | (598) | 7,741 | 2,466 | (634) | |
| Taxes on income (Tax benefit) | 742 | 863 | (461) | 1,950 | 2,103 | (489) | |
| Depreciation | 4,031 | 3,873 | 12,095 | 11,851 | 16,092 | 12,820 | |
| EBITDA | 11,608 | 8,595 | 21,476 | 19,206 | 20,801 | 22,763 |
* Convenience translation into US\$ (exchange rate as at September 30, 2023: euro 1 = US\$ 1.06)
Pursuant to the Deeds of Trust governing the Company's Series C, Series D and Series E Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 7, 2023, and below.
As of September 30, 2023, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately €77.1 million (consisting of approximately €292.5 3 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €140.2 4 million in connection with the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021), the Series D Convertible Debentures issuance (in February 2021) and the Series E Secured Debentures issuance (in February 2023), net of approximately €63.1 million of cash and cash equivalents, shortterm deposits and marketable securities and net of approximately €292.5 5 million of project finance and related hedging transactions of the Company's subsidiaries).
3 The amount of short-term and long-term debt from banks and other interest-bearing financial obligations amount provided above, includes an amount of approximately €4.5 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company's balance sheet.
4 The amount of the Debentures provided above includes an amount of approximately €1.7 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company's balance sheet.
5 The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).
The Deed of Trust governing the Company's Series C Debentures (as amended on June 6, 2022, the "Series C Deed of Trust"), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of September 30, 2023, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series C Deed of Trust) was approximately €130.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 37.2%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA6 , was 2.9.
The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended September 30, 2023:
| For the four-quarter period ended September 30, 2023 |
|||
|---|---|---|---|
| Unaudited | |||
| € in thousands | |||
| Profit for the period | 12,916 | ||
| Financing expenses, net | (5,873) | ||
| Taxes on income | (308) | ||
| Depreciation | 16,336 | ||
| Share-based payments | 130 | ||
| Adjustment to revenues of the Talmei Yosef PV Plant due to | |||
| calculation based on the fixed asset model | 3,244 | ||
| Adjusted EBITDA as defined the Series C Deed of Trust | 26,445 |
6 The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
Information for the Company's Series D Debenture Holders
The Deed of Trust governing the Company's Series D Debentures (the "Series D Deed of Trust"), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of September 30, 2023, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €130.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 37.2%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA7 was 2.9.
The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended September 30, 2023:
| For the four-quarter period ended September 30, 2023 |
||
|---|---|---|
| Unaudited | ||
| € in thousands | ||
| Profit for the period | 12,916 | |
| Financing expenses, net | (5,873) | |
| Taxes on income | (308) | |
| Depreciation and amortization expenses | 16,336 | |
| Share-based payments | 130 | |
| Adjustment to revenues of the Talmei Yosef PV Plant due to | ||
| calculation based on the fixed asset model | 3,244 | |
| Adjusted EBITDA as defined the Series D Deed of Trust | 26,445 |
7 The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
Information for the Company's Series E Debenture Holders
The Deed of Trust governing the Company's Series E Debentures (the "Series E Deed of Trust"), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of September 30, 2023, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series E Deed of Trust) was approximately €130.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 37.2%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA8 was 2.9.
The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended September 30, 2023:
| For the four-quarter period ended September 30, 2023 Unaudited € in thousands |
|
|---|---|
| Profit for the period | 12,916 |
| Financing expenses, net | (5,873) |
| Taxes on income | (308) |
| Depreciation and amortization expenses | 16,336 |
| Share-based payments | 130 |
| Adjustment to revenues of the Talmei Yosef PV Plant due to | |
| calculation based on the fixed asset model | 3,244 |
| Adjusted EBITDA as defined the Series E Deed of Trust | 26,445 |
In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. ("Ellomay Luzon Energy")), which were pledged to the holders of the Company's Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.
As of September 30, 2023, the value of the assets pledged to the holders of the Series E Debentures in the Company's books (unaudited) is approximately €33.2 million (approximately NIS 134.6 million based on the exchange rate as of such date).
8 The term "Adjusted EBITDA" is defined in the Series E Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series E Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series E Deed of Trust). The Series E Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series E Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.